Cargando…

Design and Screening of New Lead Compounds for Autism Based on QSAR Model and Molecular Docking Studies

The purpose of the present study aims to develop a satisfactory model for predicting pro-social and pro-cognitive effects on azinesulfonamides of cyclic amine derivatives as potential antipsychotics. The three dimensional-quantitative structure affinity relationship (3D-QSAR) study was performed on...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yongjian, Ma, Kang, Xu, Peilong, Si, Hongzong, Duan, Yunbo, Zhai, Honglin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657114/
https://www.ncbi.nlm.nih.gov/pubmed/36364109
http://dx.doi.org/10.3390/molecules27217285
_version_ 1784829610115989504
author Chen, Yongjian
Ma, Kang
Xu, Peilong
Si, Hongzong
Duan, Yunbo
Zhai, Honglin
author_facet Chen, Yongjian
Ma, Kang
Xu, Peilong
Si, Hongzong
Duan, Yunbo
Zhai, Honglin
author_sort Chen, Yongjian
collection PubMed
description The purpose of the present study aims to develop a satisfactory model for predicting pro-social and pro-cognitive effects on azinesulfonamides of cyclic amine derivatives as potential antipsychotics. The three dimensional-quantitative structure affinity relationship (3D-QSAR) study was performed on a series of azinesulfonamides of cyclic amine derivative using comparative molecular similarity indices analysis (CoMSIA). The best statistical model of CoMSIA q2, r2, SEE and F values are 0.664, 0.973, 0.087, and 82.344, respectively. Based on the model contour maps and the highest activity structure of the 43rd compound, serial new structures were designed and the 43k1 compound was selected as the best structure. The dock results showed a good binding of 43k1 with the protein (PDB ID: 6A93). The QSAR model analysis of the contour maps can help us to provide guidelines for finding novel potential antipsychotics.
format Online
Article
Text
id pubmed-9657114
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96571142022-11-15 Design and Screening of New Lead Compounds for Autism Based on QSAR Model and Molecular Docking Studies Chen, Yongjian Ma, Kang Xu, Peilong Si, Hongzong Duan, Yunbo Zhai, Honglin Molecules Article The purpose of the present study aims to develop a satisfactory model for predicting pro-social and pro-cognitive effects on azinesulfonamides of cyclic amine derivatives as potential antipsychotics. The three dimensional-quantitative structure affinity relationship (3D-QSAR) study was performed on a series of azinesulfonamides of cyclic amine derivative using comparative molecular similarity indices analysis (CoMSIA). The best statistical model of CoMSIA q2, r2, SEE and F values are 0.664, 0.973, 0.087, and 82.344, respectively. Based on the model contour maps and the highest activity structure of the 43rd compound, serial new structures were designed and the 43k1 compound was selected as the best structure. The dock results showed a good binding of 43k1 with the protein (PDB ID: 6A93). The QSAR model analysis of the contour maps can help us to provide guidelines for finding novel potential antipsychotics. MDPI 2022-10-26 /pmc/articles/PMC9657114/ /pubmed/36364109 http://dx.doi.org/10.3390/molecules27217285 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Chen, Yongjian
Ma, Kang
Xu, Peilong
Si, Hongzong
Duan, Yunbo
Zhai, Honglin
Design and Screening of New Lead Compounds for Autism Based on QSAR Model and Molecular Docking Studies
title Design and Screening of New Lead Compounds for Autism Based on QSAR Model and Molecular Docking Studies
title_full Design and Screening of New Lead Compounds for Autism Based on QSAR Model and Molecular Docking Studies
title_fullStr Design and Screening of New Lead Compounds for Autism Based on QSAR Model and Molecular Docking Studies
title_full_unstemmed Design and Screening of New Lead Compounds for Autism Based on QSAR Model and Molecular Docking Studies
title_short Design and Screening of New Lead Compounds for Autism Based on QSAR Model and Molecular Docking Studies
title_sort design and screening of new lead compounds for autism based on qsar model and molecular docking studies
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657114/
https://www.ncbi.nlm.nih.gov/pubmed/36364109
http://dx.doi.org/10.3390/molecules27217285
work_keys_str_mv AT chenyongjian designandscreeningofnewleadcompoundsforautismbasedonqsarmodelandmoleculardockingstudies
AT makang designandscreeningofnewleadcompoundsforautismbasedonqsarmodelandmoleculardockingstudies
AT xupeilong designandscreeningofnewleadcompoundsforautismbasedonqsarmodelandmoleculardockingstudies
AT sihongzong designandscreeningofnewleadcompoundsforautismbasedonqsarmodelandmoleculardockingstudies
AT duanyunbo designandscreeningofnewleadcompoundsforautismbasedonqsarmodelandmoleculardockingstudies
AT zhaihonglin designandscreeningofnewleadcompoundsforautismbasedonqsarmodelandmoleculardockingstudies